Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| We are excited to drive our momentum into 2024 and execute on our objectives |
| And while the culmination of these headwinds translated into an extension of time line, I am incredibly proud of how our team adapted and what we were able to achieve nonetheless |
| Not only did we receive reassurance that our -- on our path to market, but we were also pleased with the agency suggestion to include clinical data for patients outside the United States in our de novo submission, as OUS clinical data collection will meaningfully facilitate our ability to enroll patients and complete procedures |
| Thanks to these achievements and our capacity to make the difficult but necessary decisions, we concluded 2023 with the completion of each individual subsystem build for our newly architected V1.0 System, the addition of another major hospital system partnerships of clearly defined regulatory strategies, and a more resilient business structure supported by our strengthened balance sheet |
| Our distinctive system architecture founded on proprietary decoupled actuator technology not only enables superior capability but also has the potential to streamline training, enhance OR workflow, and to offer compelling economic advantages |
| First of all, we're really pleased with the progress we've made so far in the V1.0 System |
| We are confident that our innovative approach to surgical robotics, along with its array of distinctive advantages, is the cornerstone to unleashing the complete potential of this field |
| In our V1.0 System design, we incorporated enhancements for a further refined promotion profile and higher image quality with increased system safety, all with the goal of delivering the best products possible for surgeons and hospitals |
| With the resources at our disposal and our disciplined fiscal approach, we are confident in our ability to execute on our spring cadaver lab, integrate our Version 1.0 System by this fall, and achieve other important milestones |
| We maintain steadfast confidence in the potential of our unique technology and the opportunity to generate substantial value for all stakeholders |
| First, we were successful in expanding our foundational partnership with leading hospital systems as we collect feedback on the Vicarious Surgical offering and lay the ground book for commercialization |
| This included two rounds of downsizing and cost reductions, which we expect to benefit our 2024 expense profile |
| 2023 brought about meaningful milestones and strategic decisions that firmly positioned Vicarious Surgical to achieve our 2020 core objectives and advance our long-term vision of delivering innovative surgical robotic solutions to patients, surgeons and hospitals |
| Randy brings over 20 years of medical device industry experience with a track record of leadership in development, manufacturing and commercialization of innovative solutions |
| Second, we raised $47 million through an equity follow-on offering that meaningfully bolstered our balance sheet to support development, clinical and regulatory efforts in the quarters ahead |
| Through tapping into their wealth of expertise, these collaborations afford us exclusive insight instrumental in refining our products to precisely match the surgeon that hospital needs to deliver the best possible care for patients, thus ensuring our readiness for commercial success |
| Within the first month of this year, we made strides in subsystems integration |
| Throughout 2023, as we continue to press forward on product development, we made meaningful progress, particularly in the sales of each individual subsystem |
| I'd also like to express my gratitude to all Vicarious Surgical employees for their unwavering hard work and dedication |
| As a result of our disciplined spending during the year, we are pleased to have executed on our full year 2023 cash burn guidance with a burn rate of $63.4 million for the year, in line with our original full year and updated Q3 guidance |
| As we expected, Randy is already proving themselves to be an invaluable leader in asset to Vicarious Surgical as we focus on achieving our 2024 milestone |
| Adam Sachs Sounds good |
| Additionally, our architecture facilitates best-in-class visualization, sensing and data collection, all crucial for deploying and integrating automated procedural safeguards into robotic-assisted procedures |
| David played a pivotal role in our company's accomplishments over the last four years, and we'd like to extend our heartfelt gratitude to him for his guidance and support |
| Considering that only a small fraction, approximately 4%, of soft tissue surgeries currently employ robotics, there is a substantial opportunity to further alleviate the robotics value proposition for patients, surgeons and hospitals |
| 2023 was a meaningful year for Vicarious Surgical |
| We implemented initiatives to streamline resources, optimize spending and restructure the company for maximum efficiency |
| This partnership adds to our existing relationships with three of the top health care networks in the country: HCA Healthcare, University Hospitals and Pittsburgh CREATES |
| Consequently, last year, we made the difficult decision to downsize our team twice and reduce future planned expenditures, prioritizing capital efficiency and ensuring our business is better positioned to navigate such conditions |
| Thank you, everybody, for joining today's call |
| Statement |
|---|
| Continuously challenging macroeconomic conditions throughout the year created an opaque market outlook with increased capital costs |
| However, we also encountered external headwinds and met certain integration hurdles |
| GAAP net loss for the full year was $71.1 million, equating to a net loss of $0.49 per share |
Please consider a small donation if you think this website provides you with relevant information